pemafibrate
Kowa Pharmaceuticals
[]
just published in and presented aggressive lowering of triglycerides in pts with t2d had no reduction in cvd. ldl remains king for causal lipid hypotheses. 
(it’s DEER-druh) Obesity & Nutrition Epidemiologist, T2D GDM | Assistant Professor @BrighamWomens @HarvardChanSPH @HarvardMed | Editor @AJCNutrition #epitwitter